Abstract
Cancer results from the abnormal life activity of some cells in the human body. These abnormal life activities are mainly reflected in uncontrolled division and proliferation and can infiltrate and destroy normal human tissues. In actuality, more than a million people die from cancer annually, and it ranks first among the main causes of death globally. Common cancers include skin cancer, lung cancer, gastric cancer, pancreatic cancer, etc. In the modern era, immunotherapy is the mainstay of treatment for some relatively common cancers, such as breast and prostate cancer. There are many ways to treat cancer in the world. In this article, the author only compares two possible ways to treat cancer: Treg cell method and PD-1 therapy. This paper tried to clarify the advantages and disadvantages of these two immunotherapies in cancer treatment by studying and comparing the two immunotherapies for cancer treatment, to help researchers find better ways to treat cancer with immunotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
